Cargando…

Troponin utilization in patients presenting with atrial fibrillation/flutter to the emergency department: retrospective chart review

BACKGROUND: There are few recommendations about the use of cardiac markers in the investigation and management of atrial fibrillation/flutter. Currently, it is unknown how many patients with atrial fibrillation/flutter undergo troponin testing, and how positive troponin results are managed in the em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meshkat, Nazanin, Austin, Emily, Moineddin, Rahim, Hatamabadi, Hamidreza, Hassani, Behzad, Abdalvand, Ali, Marcuzzi, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126697/ https://www.ncbi.nlm.nih.gov/pubmed/21651774 http://dx.doi.org/10.1186/1865-1380-4-25

Ejemplares similares

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

DC cardioversion of atrial fibrillation and atrial flutter in the emergency department: improving specialist protocols for the generalist
por: Carpenter, Alexander, et al.
Publicado: (2018)

Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter
por: Kim, Michael H., et al.
Publicado: (2014)

Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department
por: Vinson, David R., et al.
Publicado: (2018)

Association of Intravenous Potassium and Magnesium Administration With Spontaneous Conversion of Atrial Fibrillation and Atrial Flutter in the Emergency Department
por: Cacioppo, Filippo, et al.
Publicado: (2022)

Preprocedural Troponin T Levels Predict the Improvement in the Left Ventricular Ejection Fraction After Catheter Ablation of Atrial Fibrillation/Flutter
por: Aoyama, Daisetsu, et al.
Publicado: (2020)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010)

Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
por: Malviya, Amit, et al.
Publicado: (2020)

Emergency department presentations for atrial fibrillation and flutter in Alberta: a large population-based study
por: Rosychuk, Rhonda J., et al.
Publicado: (2017)

Characteristics of patients presenting to emergency department for primary atrial fibrillation or flutter at an academic medical center
por: Sadaf, Murrium I., et al.
Publicado: (2021)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
por: Christiansen, Christine Benn, et al.
Publicado: (2010)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011)

Predictors of the Atrial Fibrillation Following Catheter Ablation of Typical Atrial Flutter.
por: Haghjoo, Majid, et al.
Publicado: (2013)

Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter
por: Stempfel, Samuel, et al.
Publicado: (2020)

The Short QTc Is a Marker for the Development of Atrial Flutter and Atrial Fibrillation
por: Rabkin, Simon W., et al.
Publicado: (2020)

Epi-endocardial asynchrony during atrial flutter followed by atrial fibrillation
por: van Staveren, Lianne N., et al.
Publicado: (2021)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Risk assessment of pre-excitation: Atrial fibrillation versus atrial flutter
por: Uniat, Jonathan, et al.
Publicado: (2022)

Admissions to the Emergency Department Due to Atrial Fibrillation/Atrial Flutter Incidents during the Third Wave of COVID-19 Pandemic
por: Chourasia, Goutam, et al.
Publicado: (2022)

Volume Matters: Improved Outcomes for Patients Presenting to High-Volume Emergency Departments with Atrial Flutter and Fibrillation
por: Rosychuk, Rhonda J., et al.
Publicado: (2016)

Racial/ethnic and sex differences in safety outcomes and atrial fibrillation/atrial flutter–related acute healthcare utilization after catheter ablation of atrial fibrillation
por: Jackson, Larry R., et al.
Publicado: (2023)

Ehrlichiosis-Induced Atrial Flutter: An Unusual Cause of Atrial Flutter
por: Kunnumpurath, Anthony, et al.
Publicado: (2020)

The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS
por: Naccarelli, Gerald V, et al.
Publicado: (2014)

Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter
por: Mont, Lluís, et al.
Publicado: (2009)

Atrial Fibrillation and Atrial Flutter in Pregnant Women—A Population‐Based Study
por: Lee, Ming‐Sum, et al.
Publicado: (2016)

Atrial flutter with alternating tachycardia cycle length after atrial fibrillation ablation
por: Ishimura, Masayuki, et al.
Publicado: (2020)

Cerebrovascular accidents differ between patients with atrial flutter and patients with atrial fibrillation
por: Staszewski, Jacek, et al.
Publicado: (2019)

Crucial role of pulmonary vein firing as an initiator of typical atrial flutter: Evidence of a close relationship between atrial fibrillation and typical atrial flutter
por: Kaneshiro, Takashi, et al.
Publicado: (2017)

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter
por: Wybraniec, Maciej T., et al.
Publicado: (2022)

Atrial fibrillation and its determinants after radiofrequency ablation of chronic common atrial flutter
por: Cade, Stéphane, et al.
Publicado: (2005)

A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter
por: Warchoł, Izabela, et al.
Publicado: (2019)

An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter
por: Sandhu, Roopinder K., et al.
Publicado: (2019)

Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter
por: Hu, Wei-Syun, et al.
Publicado: (2020)

Prevalence and Risk Factors for Preprocedural Medication Errors in Patients With Atrial Fibrillation and Atrial Flutter
por: Tuttle, Mark K., et al.
Publicado: (2021)

Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence
por: Shah, Syed Raza, et al.
Publicado: (2018)

387. Markers for Mortality in COVID-19 Patients with Atrial Fibrillation or Flutter
por: Chan, Kok Hoe, et al.
Publicado: (2020)

2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist
por: Stiell, Ian G., et al.
Publicado: (2021)

Editorial: Pathophysiological and clinical insights for atrial fibrillation/flutter or heart failure
por: Lin, Chun, et al.
Publicado: (2023)

Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis
por: Xie, Xinxing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_25s343o05ad1qh64749s2t82lh